Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma

导出原文传递

翻译打印收藏纠错

作者： Colbert,L.E. ^[1] ; Fisher,S.B. ^[2] ; Hardy,C.W. ^[3] ; Hall,W.A. ^[4] ; Saka,B. ^[5] ; Shelton,J.W. ; Petrova,A.V. ; Warren,M.D. ; Pantazides,B.G. ; Gandhi,K. ; Kowalski,J. ; Kooby,D.A. ; El-Rayes,B.F. ; StaleyIII,C.A. ; Adsay,N.V. ; CurranJr.,W.J. ; Landry,J.C. ; Maithel,S.K. ; Yu,D.S.

作者单位： Department of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine ^[1] Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Emory University ^[2] Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, United States ^[3] Department of Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, United ^[4] Department of Pathology, Winship Cancer Institute, Emory University, Atlanta, GA, United States ^[5]

关键词 biomarker mixed lineage kinase domain-like protein (MLKL)necroptosis necrosis pancreatic cancer

发布时间 2018-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交